Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vera Therapeutics, Inc. (VERA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.01-1.31 (-8.03%)
At close: 4:00PM EDT
15.01 0.00 (0.00%)
After hours: 07:09PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close16.32
Open16.91
Bid14.44 x 800
Ask15.11 x 1300
Day's Range14.43 - 17.37
52 Week Range11.30 - 33.45
Volume72,924
Avg. Volume68,385
Market Cap307.394M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.00
  • GlobeNewswire

    Vera Therapeutics to Present Phase 2a Data on Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2021 Annual Meeting

    SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients’ lives, announced today the upcoming presentation of clinical data for the Company’s lead product candidate, atacicept, from the Phase 2a JANUS clinical trial in patients with IgA nephropathy (IgAN). The data will be presented as an ePoster at the American Society of Nephrolo

  • GlobeNewswire

    Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy

    SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients’ lives, announced today that it is scheduled to host a key opinion leader (KOL) webinar on IgA Nephropathy (IgAN or Berger’s Disease) at 12:00 p.m. ET on Monday, September 20, 2021. The event will feature presentations by KOLs Richard Lafayette M.D., Stanford University Medi

  • Benzinga

    53 Biggest Movers From Friday

    Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera Therapeutics, Inc. (NASDAQ: VERA) gained 32.7% to close at $25.80. Vera Therapeutics, last month, reported a Q2 loss of $0.33 per share. Spire Global, Inc. (NYSE: SPIR) gained 29.1% to settle at $11.85. Spire recently secured an order to provide commercial radio occultation (RO) weather data for the National Oceanographic and Ocea

Advertisement
Advertisement